Skip to content

Unifarma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Unifarma

BE 0422.674.530
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€122,718
2024 · -€1,762+€124,480
Equity
€3.3m
2024 · €3.3m-€41,952
Cash
€191,036
2024 · €270,893-€79,857
Balance sheet total
€3.6m
2024 · €3.7m-€163,221

Largest movements

2024 to 2025
Assets
  • Cash -€79,857

    down €79,857 (-29.5%), from €270,893 to €191,036

    mainly Contributions, distributions and other (-€164,670) and Trade debts (-€48,590)

  • Stocks and contracts -€78,901

    down €78,901 (-11.7%), from €673,085 to €594,184

  • Tangible fixed assets -€42,464

    down €42,464 (-10.9%), from €388,916 to €346,452

    of which Plant, machinery and equipment: -€36,554

Equity and liabilities
  • Reserves -€164,670

    down €164,670 (-54.8%), from €300,537 to €135,867

    of which Distributable reserves: -€164,670

  • Profit (loss) carried forward +€122,718

    up €122,718 (+4.1%), from €3.0m to €3.1m

  • Trade debts -€48,590

    down €48,590 (-22.3%), from €218,019 to €169,430

  • Other debts -€43,059

    down €43,059 (-65.7%), from €65,539 to €22,480

Income statement
  • Financial income +€138,720

    up €138,720 (+349.7%), from €39,673 to €178,394

    of which Non-recurring financial income: +€150,000

  • Gross operating margin -€20,651

    down €20,651 (-3.8%), from €537,792 to €517,141

  • Staff costs -€20,329

    down €20,329 (-3.9%), from €525,826 to €505,497

  • Depreciation +€14,822

    up €14,822 (+39.5%), from €37,477 to €52,299

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€1,762
Gross operating margin -€20,651
Staff costs +€20,329
Depreciation -€14,822
Other operating charges -€3,063
Financial income +€138,720
Financial charges +€4,017
Taxes -€52
Result 2025 €122,718

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€128,643
Investment -€43,830
Financing -€164,670
Cash 2024 €270,893
Net result for the year +€122,718
Depreciation +€52,299
Stocks and contracts +€78,901
Receivables within one year -€1,868
Deferred charges and accrued income -€2,138
Trade debts -€48,590
Tax, wage and social debts -€29,621
Other debts -€43,059
Investment in fixed assets (net) -€9,835
Current investments -€33,995
Contributions, distributions and other -€164,670
Cash 2025 €191,036
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,722,481 €3,559,260 -€163,221 -4.4%
Fixed assets 21/28 €388,916 €346,452 -€42,464 -10.9%
Tangible fixed assets 22/27 €388,916 €346,452 -€42,464 -10.9%
Plant, machinery and equipment 23 €382,035 €345,480 -€36,554 -9.6%
Furniture and vehicles 24 €6,881 €971 -€5,910 -85.9%
Current assets 29/58 €3,333,565 €3,212,808 -€120,757 -3.6%
Stocks and contracts in progress 3 €673,085 €594,184 -€78,901 -11.7%
Stocks 30/36 €673,085 €594,184 -€78,901 -11.7%
Amounts receivable within one year 40/41 €386,956 €388,824 +€1,868 +0.5%
Trade receivables 40 €376,740 €371,150 -€5,590 -1.5%
Other amounts receivable 41 €10,216 €17,674 +€7,458 +73.0%
Current investments 50/53 €2,002,630 €2,036,626 +€33,995 +1.7%
Cash at bank and in hand 54/58 €270,893 €191,036 -€79,857 -29.5%
Deferred charges and accrued income 490/1 - €2,138 +€2,138
Total equity and liabilities 10/49 €3,722,481 €3,559,260 -€163,221 -4.4%
Equity 10/15 €3,345,095 €3,303,143 -€41,952 -1.3%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €300,537 €135,867 -€164,670 -54.8%
Non-distributable reserves 130/1 €10,075 €10,075 = 0.0%
Legal reserve 130 €10,075 €10,075 = 0.0%
Tax-exempt reserves 132 €2,975 €2,975 = 0.0%
Distributable reserves 133 €287,487 €122,817 -€164,670 -57.3%
Profit (loss) carried forward 14 €2,982,559 €3,105,277 +€122,718 +4.1%
Amounts payable 17/49 €377,385 €256,116 -€121,269 -32.1%
Amounts payable within one year 42/48 €377,385 €256,116 -€121,269 -32.1%
Trade debts 44 €218,019 €169,430 -€48,590 -22.3%
Suppliers 440/4 €218,019 €169,430 -€48,590 -22.3%
Taxes, remuneration and social security 45 €93,827 €64,206 -€29,621 -31.6%
Taxes 450/3 €3,364 €2,356 -€1,009 -30.0%
Remuneration and social security 454/9 €90,463 €61,851 -€28,612 -31.6%
Other amounts payable 47/48 €65,539 €22,480 -€43,059 -65.7%
Remuneration, social security and pensions 62 €525,826 €505,497 -€20,329 -3.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €37,477 €52,299 +€14,822 +39.5%
Other operating charges 640/8 €4,368 €7,431 +€3,063 +70.1%
Gross operating margin 9900 €537,792 €517,141 -€20,651 -3.8%
Operating profit (loss) 9901 -€29,880 -€48,085 -€18,206 -60.9%
Financial income 75/76B €39,673 €178,394 +€138,720 +349.7%
Recurring financial income 75 €39,673 €28,394 -€11,280 -28.4%
Non-recurring financial income 76B - €150,000 +€150,000
Financial charges 65/66B €10,562 €6,545 -€4,017 -38.0%
Recurring financial charges 65 €10,562 €6,545 -€4,017 -38.0%
Profit (loss) for the period before taxes 9903 -€768 €123,764 +€124,532
Income taxes 67/77 €994 €1,046 +€52 +5.2%
Profit (loss) for the period 9904 -€1,762 €122,718 +€124,480
Profit (loss) for the period to be appropriated 9905 -€1,762 €122,718 +€124,480

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.